Five year overall survival following mayo protocol for hilar cholangiocarcinoma justifies its continued use; the Dublin experience. (2019) - Fiore, B.; Ismail, M.; Gallagher, T.K.; Houlihan, D.; Geoghegan, J.; MacNicholas, R.; Maguire, D.; McCormick, A.; Stafford, A.; Traynor, O.; Hoti, E.